CRL

CHARLES RIVER LABORATORIES

CRL·159864107·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

CRL (CHARLES RIVER LABORATORIES) is held by 232 institutional investors as of Q2 2026. Largest holders: FMR LLC ($961.5M), BlackRock, Inc. ($861.5M), VANGUARD CAPITAL MANAGEMENT LLC ($714.2M). Net institutional sentiment: Mixed.

232
Holders
(22 Elite)
$11.6B
Total Value
50% (235)
Consensus
117 buying - 118 selling
13F: Insider & Congress: Updated regularly
CRL

Smart Money Verdict

View all
Loading verdict
Held by 232 funds
22 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 27, 2026 · Activists Aug 13, 2026 · Congress none

InsiderFCFOSTER JAMES CSell $10.1MAug 25, 2026
InsiderFCFOSTER JAMES CExercise 12K shAug 25, 2026
InsiderFCFOSTER JAMES CExercise 21K shAug 25, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.2M(+22.7%)$961.5M0.0%+55.41%
39
Decreased
3.8M(-1.6%)$861.5M0.0%+61.39%
0
Decreased
3.1M(-1.6%)$714.2M0.0%+71.07%
0
Increased
3M(+24.5%)$676.9M0.1%+35.05%
39
Increased
2.2M(+4.1%)$508.3M0.7%+79.84%
46
Decreased
2.2M(-3.6%)$501.4M0.0%+71.07%
0
Decreased
1.9M(-4.4%)$436.5M0.7%+51.57%
0
Decreased
1.9M(-0.5%)$422.8M0.0%+26.03%
0
Decreased
1.6M(-0.2%)$373.8M0.1%+60.25%
0
Increased
1.5M(+4.3%)$341.6M3.4%+57.65%
59
Increased
1.3M$295.6M0.0%+31.82%
31
Decreased
1.3M(-20.9%)$292.2M0.1%+52.30%
0
Decreased
1.2M(-1.5%)$270.7M0.0%+65.64%
0
Increased
1.2M(+3.3%)$265.9M0.0%+67.40%
32
Increased
1.1M(+15.3%)$254M0.9%+48.72%
50
Decreased
881,189(-20.6%)$199.8M0.0%+62.69%
0
Decreased
862,704(-1.3%)$195.6M0.1%+97.52%
0
Increased
813,530(+7.5%)$184.5M0.2%+51.68%
39
Decreased
800,487(-3.0%)$181.5M0.0%+62.41%
0
Increased
781,276(+23.5%)$177.2M0.1%+22.12%
44

Showing 1-20 of 246

1 / 13
CRLCRLCHARLES RIVER LABORATORIES

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used